More than 1.7 million women worldwide contract breast cancer every year, and about half a million occurrences are fatal. While there has been increasing progress in the field of therapy in recent years, there has also been progress in the field of diagnostics. The latest development now comes from Switzerland, where researchers at the University of Zurich (UZH) have found a way to label breast cancer antibodies simply and quickly.
Get full access to our archive by becoming a member of Innovation Origins. Sign up here as a supporter of independent journalism!
Become a member!
On Innovation Origins you can read the latest news about the world of innovation every day. We want to keep it that way, but we can't do it alone! Are you enjoying our articles and would you like to support independent journalism? Become a member and read our stories guaranteed ad-free.